PHENOTYPES OF BRONCHIAL ASTHMA AND MODERN CHOICE OF THERAPY
PDF

Keywords

bronchial asthma, bronchial asthma phenotypes, inhaled glucocorticosteroids.

How to Cite

Mamadjanov , R. (2026). PHENOTYPES OF BRONCHIAL ASTHMA AND MODERN CHOICE OF THERAPY. INTERNATIONAL CONFERENCE ON SCIENCE, INNOVATION AND GLOBAL DEVELOPMENT, 1(3), 69-84. https://doi.org/10.5281/zenodo.18956025

Abstract

Bronchial asthma (BA), being one of the most common chronic diseases of humans, is characterized by a high heterogeneity of clinical forms and variability of the course. The heterogeneity of BA manifests itself in varying degrees of bronchial obstruction severity, varying frequency of exacerbations, varying responses to bronchodilators and long-term control drugs, in particular, inhaled glucocorticosteroids. Modern management of BA requires a thorough analysis of the factors responsible for the progression of the disease and the development of exacerbations, as well as the development of targeted therapy for BA, taking into account the clinical and biological phenotypes of the disease. However, even now, in most patients with asthma, therapy can be conducted taking into account the phenotype of the disease, which is an important task of a specialist physician.

PDF

References

1. Rackemann F.M. // Am. J. Med. Sci. 1921. V. 12. P. 802.

2. Turner-Warwick M. // Br. J. Dis. Chest. 1977. V. 71. P. 73.

3. Федосеев Г.Б. Современное представление о причинах возникновения, особенностях течения и лечения бронхиальной астмы: Актовая речь. Л., 1982.

4. Wenzel S. // Lancet. 2006. V. 368. P. 804.

5. Johansson S.G. et al. // Allergy. 2001. V. 56. P. 813.

6. Simpson J.L. et al. // Respirology. 2006. V. 11. P. 54.

7. Nasser S.M. et al. // Am. J. Respir. Crit. Care Med. 1996. V. 153. P. 90.

8. Frew A.J. et al. // Am. J. Respir. Crit. Care Med. 1995. V. 151. P. 340.

9. Green R.H. et al. // Lancet. 2002. V. 360. P. 1715.

10. Jayaram L. et al. // Eur. Respir. J. 2006. V. 27. P. 483.

11. Simpson J.L. et al. // Am. J. Respir. Crit. Care Med. 2005. V. 172. P. 559.

12. Cundall M. et al. // J. Allergy Clin. Immunol. 2003. V. 112. P. 1064.

13. Green R.H. et al. // Thorax. 2002. V. 57. P. 875.

14. Berry M. et al. // Thorax. 2007. V. 62. P. 1043.

15. Cox G. // J. Immunol. 1995. V. 154. P. 4719.

16. Nguyen L.T. et al. // Respir. Med. 2005. V. 99. P. 200.

17. Petsky H.L. et al. // Thorax. 2012. V. 67. P. 199.

18. Green R.H., Pavord I. // Thorax. 2012. V. 67. P. 665.

19. Haldar P. et al. // Am. J. Respir. Crit. Care Med. 2008. V. 178. P. 218.

20. Moore W.C. et al. // Am. J. Respir. Crit. Care Med. 2010. V. 181. P. 315.

21. Wenzel S. // Clin. Exp. Allergy. 2012. V. 42. P. 650.

22. Anderson G.P. // Lancet. 2008. V. 372. P. 1107.

23. Lötvall J. et al. // J. Allergy Clin. Immunol. 2011. V. 127. P. 355.

24. Difficult-to-Treat Severe Asthma / Ed. by K.F. Chung et al. Eur. Respir. Mon. 2011. V. 51.

25. Walter S. et al. // Cochrane Database Syst. Rev. 2006. № 2. CD003559.

26. Rodrigo G.J. et al. // Chest. 2011. V. 139. P. 28.

27. Deeks E.D. et al. // Drugs. 2008. V. 68. P. 1741.

28. Tan R.A., Corren J. // Ther. Clin. Risk. Manag. 2008. V. 4. P. 1201.

29. Barnes P.J. // Eur. Respir. J. 2002. V. 19. P. 182.

30. Bai T.R. et al. // Eur. Respir. J. 2007. V. 30. P. 452.

31. Wu A.C. et al. // Chest. 2011. V. 140. P. 100.

Downloads

Download data is not yet available.